NCT04044664 - Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

August 5, 2020

Study Completion Date

August 5, 2020

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG

Placebo oral capsule

Matching placebo capsules.

DRUG

NYX-783

NYX-783 is a small molecule that modulates the N-methyl-D-aspartate receptor (NMDAR).

Trial Locations (37)

10036

Aptinyx Clinical Site, New York

10312

Aptinyx Clinical Site, Staten Island

11516

Aptinyx Clinical Site, Cedarhurst

28144

Aptinyx Clinical Site, Salisbury

30322

Aptinyx Clinical Site, Little Rock

30329

Aptinyx, Atlanta

30331

Aptinyx Clinical Site, Atlanta

32256

Aptinyx Clinical Site, Jacksonville

32591

Aptinyx Clinical Site, Temecula

32801

Aptinyx Clinical Site, Orlando

33319

Aptinyx Clinical Site, Lauderhill

35404

Aptinyx Clinical Site, Tuscaloosa

38119

Aptinyx Clinical Site, Memphis

44720

Aptinyx Clinical Site, Canton

45219

Aptinyx Clinical Site, Cincinnati

60619

Aptinyx Clinical Site, Hoffman Estates

73107

Aptinyx Clinical Site, Oklahoma City

78229

Aptinyx Clinical Site, San Antonio

78737

Aptinyx Clinical Site, Austin

80910

Aptinyx Clinical Site, Colorado Springs

85012

Aptinyx Clinical Site, Phoenix

89102

Aptinyx Clinical Site, Las Vegas

90502

Aptinyx Clinical Site, Torrance

90706

Aptinyx Clinical Site, Bellflower

91206

Aptinyx Clinical Site, Glendale

92056

Aptinyx Clinical Site, Oceanside

92078

Aptinyx Clinical Site, San Marcos

92103

Aptinyx Clinical Site, San Diego

92251

Aptinyx Clinical Site, Imperial

92503

Aptinyx Clinical Site, Riverside

92705

Aptinyx Clinical Site, Santa Ana

92868

Aptinyx Clinical Site, Orange

94607

Aptinyx Clinical Site, Oakland

98007

Aptinyx Clinical Site, Bellevue

06360

Aptinyx Clinical Site, Norwich

02131

Aptinyx Clinical Site, Boston

08009

Aptinyx Clinical Site, Berlin